ARTICLE | Clinical News
Taxotere docetaxel regulatory update
July 3, 2006 7:00 AM UTC
The U.K.'s National Institute for Health and Clinical Excellence (NICE) released guidance recommending that all eligible patients can have access to Taxotere to treat hormone-refractory prostate cance...